xwell - XWEL

XWEL

Close Chg Chg %
0.62 -0.04 -6.21%

Closed Market

0.58

-0.04 (6.21%)

Volume: 93.45K

Last Updated:

Dec 29, 2025, 4:00 PM EDT

Company Overview: xwell - XWEL

XWEL Key Data

Open

$0.59

Day Range

0.52 - 0.63

52 Week Range

0.52 - 1.69

Market Cap

$3.58M

Shares Outstanding

5.77M

Public Float

4.30M

Beta

1.23

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$3.16

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

22.30K

 

XWEL Performance

1 Week
 
-7.75%
 
1 Month
 
-24.99%
 
3 Months
 
-42.12%
 
1 Year
 
-65.02%
 
5 Years
 
-97.60%
 

XWEL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About xwell - XWEL

XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Naples Wax Center segment is focused on the products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.

XWEL At a Glance

XWELL, Inc.
254 West 31st Street
New York, New York 10001
Phone 1-212-750-9595 Revenue 33.90M
Industry Other Consumer Services Net Income -16,853,000.00
Sector Consumer Services 2024 Sales Growth 12.581%
Fiscal Year-end 12 / 2025 Employees 312
View SEC Filings

XWEL Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.205
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1.472
Enterprise Value to Sales 0.427
Total Debt to Enterprise Value 0.744

XWEL Efficiency

Revenue/Employee 108,644.231
Income Per Employee -54,016.026
Receivables Turnover 18.905
Total Asset Turnover 1.054

XWEL Liquidity

Current Ratio 1.663
Quick Ratio 1.608
Cash Ratio 1.279

XWEL Profitability

Gross Margin 23.545
Operating Margin -35.699
Pretax Margin -48.503
Net Margin -49.718
Return on Assets -52.383
Return on Equity -275.962
Return on Total Capital -168.885
Return on Invested Capital -115.069

XWEL Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 107.897
Total Debt to Total Assets 42.47
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 84.036
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Xwell - XWEL

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
73.73M 55.94M 30.11M 33.90M
Sales Growth
+779.30% -24.13% -46.18% +12.58%
Cost of Goods Sold (COGS) incl D&A
44.59M 49.32M 28.49M 25.92M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.92M 7.27M 3.55M 2.27M
Depreciation
4.47M 5.51M 2.31M 1.96M
Amortization of Intangibles
447.00K 1.77M 1.24M 316.00K
COGS Growth
+159.33% +10.62% -42.23% -9.04%
Gross Income
29.14M 6.62M 1.62M 7.98M
Gross Income Growth
+430.87% -77.29% -75.59% +393.87%
Gross Profit Margin
+39.53% +11.83% +5.37% +23.54%
2021 2022 2023 2024 5-year trend
SG&A Expense
24.20M 31.17M 20.91M 20.08M
Research & Development
- - - -
-
Other SG&A
24.20M 31.17M 20.91M 20.08M
SGA Growth
+51.81% +28.80% -32.91% -3.96%
Other Operating Expense
- - - -
-
Unusual Expense
837.00K 6.40M 8.93M 4.16M
EBIT after Unusual Expense
4.11M (30.95M) (28.23M) (16.26M)
Non Operating Income/Expense
(1.16M) (1.17M) 553.00K (1.00K)
Non-Operating Interest Income
43.00K 384.00K 448.00K 380.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 462.00K 321.00K 179.00K
Interest Expense Growth
- - -30.52% -44.24%
-
Gross Interest Expense
- 462.00K 321.00K 179.00K
Interest Capitalized
- - - -
-
Pretax Income
2.95M (32.57M) (27.99M) (16.44M)
Pretax Income Growth
+103.20% -1,204.58% +14.06% +41.27%
Pretax Margin
+4.00% -58.23% -92.98% -48.50%
Income Tax
56.00K 55.00K 35.00K 49.00K
Income Tax - Current - Domestic
56.00K 41.00K 15.00K 30.00K
Income Tax - Current - Foreign
- 14.00K 20.00K 19.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.89M (32.63M) (28.03M) (16.49M)
Minority Interest Expense
(456.00K) 208.00K (288.00K) 363.00K
Net Income
3.35M (32.84M) (27.74M) (16.85M)
Net Income Growth
+103.70% -1,080.50% +15.52% +39.25%
Net Margin Growth
+4.54% -58.70% -92.14% -49.72%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
3.35M (32.84M) (27.74M) (16.85M)
Preferred Dividends
- - - -
-
Net Income Available to Common
3.35M (32.84M) (27.74M) (16.85M)
EPS (Basic)
0.6422 -7.0124 -6.6442 -3.655
EPS (Basic) Growth
+101.57% -1,191.93% +5.25% +44.99%
Basic Shares Outstanding
5.22M 4.68M 4.18M 4.61M
EPS (Diluted)
0.6374 -7.0124 -6.6442 -3.655
EPS (Diluted) Growth
+101.55% -1,200.16% +5.25% +44.99%
Diluted Shares Outstanding
5.25M 4.68M 4.18M 4.61M
EBITDA
9.86M (17.28M) (15.75M) (9.83M)
EBITDA Growth
+156.29% -275.15% +8.84% +37.60%
EBITDA Margin
+13.38% -30.89% -52.31% -28.99%

Xwell in the News